| Product Code: ETC13249663 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Drug Screening Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Drug Screening Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Drug Screening Market Revenues & Volume, 2021 & 2031F |
3.3 North America Drug Screening Market - Industry Life Cycle |
3.4 North America Drug Screening Market - Porter's Five Forces |
3.5 North America Drug Screening Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Drug Screening Market Revenues & Volume Share, By Product & Service, 2021 & 2031F |
3.7 North America Drug Screening Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
3.8 North America Drug Screening Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 North America Drug Screening Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Drug Screening Market Trends |
6 North America Drug Screening Market, 2021 - 2031 |
6.1 North America Drug Screening Market, Revenues & Volume, By Product & Service, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Drug Screening Market, Revenues & Volume, By Equipment, 2021 - 2031 |
6.1.3 North America Drug Screening Market, Revenues & Volume, By Rapid Testing Devices, 2021 - 2031 |
6.1.4 North America Drug Screening Market, Revenues & Volume, By Consumables, 2021 - 2031 |
6.1.5 North America Drug Screening Market, Revenues & Volume, By Laboratory Services, 2021 - 2031 |
6.2 North America Drug Screening Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Drug Screening Market, Revenues & Volume, By Urine Sample, 2021 - 2031 |
6.2.3 North America Drug Screening Market, Revenues & Volume, By Breath Sample, 2021 - 2031 |
6.2.4 North America Drug Screening Market, Revenues & Volume, By Oral Fluid Sample, 2021 - 2031 |
6.2.5 North America Drug Screening Market, Revenues & Volume, By Hair Sample, 2021 - 2031 |
6.2.6 North America Drug Screening Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 North America Drug Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Drug Screening Market, Revenues & Volume, By Workplace and Schools, 2021 - 2031 |
6.3.3 North America Drug Screening Market, Revenues & Volume, By Drug Testing Laboratories, 2021 - 2031 |
6.3.4 North America Drug Screening Market, Revenues & Volume, By Criminal Justice System & Law Enforcement Agencies, 2021 - 2031 |
6.3.5 North America Drug Screening Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.6 North America Drug Screening Market, Revenues & Volume, By Drug Treatment Centers, 2021 - 2031 |
6.3.7 North America Drug Screening Market, Revenues & Volume, By Pain Management Centers, 2021 - 2031 |
6.3.8 North America Drug Screening Market, Revenues & Volume, By Personal Users, 2021 - 2031 |
7 North America Drug Screening Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Drug Screening Market, Revenues & Volume, By Product & Service, 2021 - 2031 |
7.2.1 United States (US) Drug Screening Market, Revenues & Volume, By Product & Service, 2021 - 2031 |
7.2.2 Canada Drug Screening Market, Revenues & Volume, By Product & Service, 2021 - 2031 |
7.2.3 Rest of North America Drug Screening Market, Revenues & Volume, By Product & Service, 2021 - 2031 |
7.3 North America Drug Screening Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
7.3.1 United States (US) Drug Screening Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
7.3.2 Canada Drug Screening Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
7.3.3 Rest of North America Drug Screening Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
7.4 North America Drug Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.1 United States (US) Drug Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.2 Canada Drug Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.3 Rest of North America Drug Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
8 North America Drug Screening Market Key Performance Indicators |
9 North America Drug Screening Market - Export/Import By Countries Assessment |
10 North America Drug Screening Market - Opportunity Assessment |
10.1 North America Drug Screening Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Drug Screening Market Opportunity Assessment, By Product & Service, 2021 & 2031F |
10.3 North America Drug Screening Market Opportunity Assessment, By Sample Type, 2021 & 2031F |
10.4 North America Drug Screening Market Opportunity Assessment, By End User, 2021 & 2031F |
11 North America Drug Screening Market - Competitive Landscape |
11.1 North America Drug Screening Market Revenue Share, By Companies, 2022 |
11.2 North America Drug Screening Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here